Osage Partners related stories
All articles and analysis
Escape Bio nabs $73mEscape Bio, a developer of treatments for genetic neurodegenerative diseases, has raised $73 million in financing.
SiFive amasses $61m Series ESiFive Inc, a provider of commercial RISC-V processor IP and silicon solutions, has raised $61 million in Series E funding.
- Aerovate Therapeutics scoops up $72.6m Series A
Aerovate Therapeutics Inc, a biotech company, has raised $72.6 million in Series A funding.
- StreetLight Data pulls in $15m Series D
StreetLight Data Inc, a provider of big data analytics for mobility, has secured $15 million in Series D funding.
- Vor Biopharma picks up $110m Series B
Cambridge, Massachusetts-based Vor Biopharma, an oncology company, has raised $110 million in a Series B financing.
Gilead Sciences to acquires stake in VC-backed PionyrGilead Sciences Inc has agreed to acquire 49.9 percent stake in Pionyr Immunotherapeutics Inc, a developer of cancer immunotherapies.
VMWare to buy VC-backed cybersecurity firm LastlineVMWare has agreed to acquire cybersecurity company and breach detection platform Lastline, according to a blog post.
- ReCode Therapeutics nabs $80m Series A
ReCode Therapeutics, a provider of precision medicines for pulmonary diseases, has raised $80 million in Series A financing.
- OVP adds principal to team
Osage Venture Partners has named Emily Foote as a principal.
- Osage Venture Partners ups Dowling to partner
Osage Venture Partners has promoted Sean Dowling to partner.